Treatment of neuroblastoma.
D000367:Age Factors; D001859:Bone Neoplasms; D002395:Catecholamines / Q000652:urine; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008207:Lymphatic Metastasis; D008297:Male; D009362:Neoplasm Metastasis; D009365:Neoplasm Regression, Spontaneous; D009447:Neuroblastoma / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D009638:Norepinephrine / Q000652:urine; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use
D002395:Catecholamines; D014750:Vincristine; D003520:Cyclophosphamide; D009638:Norepinephrine; D003630:Daunorubicin